NRSN logo

NeuroSense Therapeutics Ltd.

NRSN
Healthcare|Biotechnology|IL
$1.68
+0.28 (+20.43%)
Cash / Share
$0.18

Ownership Breakdown

62.9%
Float
1.9M
Shares Outstanding
1.2M
Float Shares

Major Holders (3)

Combined: 30.0%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Rimon Gold Assets Ltd.Corporation9.99%2,303,729Dec 9, 202413D/G
Abir RavehIN, OO9.99%2,303,729Dec 9, 202413D/G
Goldfinger TrustOther9.99%2,303,729Dec 9, 202413D/G

Insider Trades (48)

Last 4 quarters: 1,100,000 acquired · 0 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Ben-Noon AlonChief Executive OfficerJun 16, 2026BUY250,000$0.80$200.0KForm 4
Eisenberg OrChief Financial OfficerJun 16, 2026BUY250,000$0.80$200.0KForm 4
Eisenberg OrChief Financial OfficerMar 26, 2026AWARD200,000——Form 4
Eisenberg OrChief Financial OfficerMar 18, 2026OTHER0——Form 4
Eisenberg OrChief Financial OfficerMar 18, 2026OTHER0——Form 4
Eisenberg OrChief Financial OfficerMar 18, 2026OTHER0——Form 4
Eisenberg OrChief Financial OfficerJul 1, 2021OTHER21,000$0.03$693.00Form 4
Eisenberg OrChief Financial OfficerAug 15, 2024OTHER66,666$0.75$50.0KForm 4
Mandil-Levin RevitaldirectorMar 18, 2026OTHER0——Form 4
Mandil-Levin RevitaldirectorMar 18, 2026OTHER0——Form 4
Mandil-Levin RevitaldirectorMar 18, 2026OTHER0——Form 4
Mandil-Levin RevitaldirectorMar 10, 2023OTHER72,000$1.43$103.0KForm 4
Russek-Blum NivaChief Technology OfficerMar 26, 2026AWARD200,000——Form 4
Russek-Blum NivaChief Technology OfficerMar 18, 2026OTHER0——Form 4
Russek-Blum NivaChief Technology OfficerMar 18, 2026OTHER0——Form 4
Russek-Blum NivaChief Technology OfficerMar 18, 2026OTHER0——Form 4
Russek-Blum NivaChief Technology OfficerMar 18, 2026OTHER0——Form 4
Russek-Blum NivaChief Technology OfficerApr 25, 2022OTHER36,000$2.18$78.5KForm 4
Ben-Noon Alon10 percent owner, officer: Chief Executive OfficerMar 18, 2026OTHER0——Form 4
Ben-Noon Alon10 percent owner, officer: Chief Executive OfficerMar 18, 2026OTHER0——Form 4
Ben-Noon Alon10 percent owner, officer: Chief Executive OfficerMar 18, 2026OTHER0——Form 4
Ben-Noon Alon10 percent owner, officer: Chief Executive OfficerAug 15, 2024OTHER26,666$0.75$20.0KForm 4
Ben-Noon Alon10 percent owner, officer: Chief Executive OfficerDec 5, 2024OTHER80,000$1.25$100.0KForm 4
Binder HagitGeneral ManagerMar 26, 2026AWARD200,000——Form 4
Pellizzari Christine AdirectorMar 18, 2026OTHER0——Form 4
Pellizzari Christine AdirectorMar 18, 2026OTHER0——Form 4
Pellizzari Christine AdirectorMar 18, 2026OTHER0——Form 4
Pellizzari Christine AdirectorMar 10, 2023OTHER72,000$1.43$103.0KForm 4
Tracik FerencChief Medical OfficerMar 18, 2026OTHER0——Form 4
Tracik FerencChief Medical OfficerMar 18, 2026OTHER0——Form 4
Tracik FerencChief Medical OfficerMar 13, 2022OTHER108,000$3.51$379.1KForm 4
Tracik FerencChief Medical OfficerAug 15, 2024OTHER66,667$0.75$50.0KForm 4
Claiborne Cary JdirectorMar 18, 2026OTHER0——Form 4
Claiborne Cary JdirectorMar 18, 2026OTHER0——Form 4
Claiborne Cary JdirectorMar 18, 2026OTHER0——Form 4
Claiborne Cary JdirectorMar 10, 2023OTHER72,000$1.43$103.0KForm 4
Golan RoydirectorMar 18, 2026OTHER0——Form 4
Golan RoydirectorMar 18, 2026OTHER0——Form 4
Golan RoydirectorMar 18, 2026OTHER0——Form 4
Leuchtenberger MarkdirectorMar 18, 2026OTHER0——Form 4
Leuchtenberger MarkdirectorMar 18, 2026OTHER0——Form 4
Leuchtenberger MarkdirectorMar 18, 2026OTHER0——Form 4
Leuchtenberger MarkdirectorJan 1, 2022OTHER192,000$3.51$673.9KForm 4
Binder HagitGeneral ManagerMar 18, 2026OTHER0——Form 4
Binder HagitGeneral ManagerMar 18, 2026OTHER0——Form 4
Binder HagitGeneral ManagerMar 18, 2026OTHER0——Form 4
Binder HagitGeneral ManagerMar 18, 2026OTHER0——Form 4
Binder HagitGeneral ManagerNov 17, 2022OTHER36,000$1.99$71.6KForm 4